Quantification and reduction of cardiac dose in radical radiotherapy for oesophageal cancer

British Journal of Radiology

Volumn 78, Issue 936, 2005, Pages 1069-1074

  Cominos, M ^a,b   Mosleh Shirazi, M A ^a   Tait, D ^a   Henrys, A ^a   Cornes, P ^a,c  

^a ROYAL MARSDEN HOSPITAL   (United Kingdom)

^b MAIDSTONE HOSPITAL   (United Kingdom)

^c BRISTOL HAEMATOLOGY AND ONCOLOGY CENTRE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; PLATINUM;

ADULT; AGED; ARTICLE; CANCER LOCALIZATION; CANCER PATIENT; CARDIOTOXICITY; CLINICAL ARTICLE; COMORBIDITY; CONTROLLED STUDY; ESOPHAGUS CANCER; HEART DISEASE; HEART VOLUME; HUMAN; INCIDENCE; INTERMETHOD COMPARISON; PATIENT SELECTION; RADIATION BEAM; RADIATION DOSE; RADIATION FIELD; STATISTICAL SIGNIFICANCE; TREATMENT PLANNING;

AGED; AGED, 80 AND OVER; ANTIMETABOLITES, ANTINEOPLASTIC; CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; ESOPHAGEAL NEOPLASMS; FLUOROURACIL; HEART; HUMANS; MIDDLE AGED; RADIATION DOSAGE; RADIATION INJURIES; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, CONFORMAL; TOMOGRAPHY, X-RAY COMPUTED;

EID: 29644431945     PISSN: 00071285     EISSN: None     Source Type: Journal    
DOI: 10.1259/bjr/20742408     Document Type: Article

References (18)

1. http://www.cancerresearchuk.org/aboutcancer/statistics/ [Accessed June 2004].
2. Enzinger PC, Mayer RJ. Esophageal cancer. N Engl J Med 2003;349:2241-52.
3. Sykes AJ, Burt PA, Slevin NJ, Stout R, Marrs JE. Radical radiotherapy for carcinoma of the oesophagus: an effective alternative to surgery. Radiother Oncol 1998;48:15-21.
4. al-Sarraf M, Martz K, Herskovic A, Leichman L, Brindle JS, Vaitkevicius VK, et al. Progress report of combined chemoradiotherapy versus radiotherapy alone in patients with esophageal cancer: an intergroup study. J Clin Oncol 1997;15:277-84.
5. Cooper JS, Guo MD, Herskovic A, Macdonald JS, Martenson JA Jr, Al-Sarraf M, et al. Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-01). Radiation Therapy Oncology Group. JAMA 1999;281:1623-7.
6. Smith TJ, Ryan LM, Douglass HO Jr, Haller DG, Dayal Y, Kirkwood J, et al. Combined chemoradiotherapy vs. radiotherapy alone for early stage squamous cell carcinoma of the esophagus: a study of the Eastern Cooperative Oncology Group. Int J Radiat Oncol Biol Phys 1998;42:269-76.
7. Waters JS, Tait D, Cunningham D, Padhani AR, Hill ME, Falk S, et al. A multicentre phase II trial of primary chemotherapy with cisplatin and protracted venous infusion 5-fluorouracil followed by chemoradiation in patients with carcinoma of the oesophagus. Ann Oncol 2002;13:1763-70.
8. Boivin JF, Hutchison GB, Lubin JH, Mauch P. Coronary artery disease mortality in patients treated for Hodgkin's disease. Cancer 1992;69:1241-7.
9. Hancock SL, Donaldson SS, Hoppe RT. Cardiac disease following treatment of Hodgkin's disease in children and adolescents. J Clin Oncol 1993;11:1208-15.
10. Adams MJ, Hardenbergh PH, Constine LS, Lipshultz SE. Radiation-associated cardiovascular disease. Crit Rev Oncol Hematol 2003;45:55-75.
11. Early Breast Cancer Trialists' Collaborative Group. Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: an overview of the randomized trials. Lancet 2000;355:1757-70.
12. Emami B, Lyman J, Brown A, Coia L, Goitein M, Munzenrider JE, et al. Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys 1991;21:109-22.
13. Irvine C, Morgan A, Crellin A, Nisbet A, Beange I. The clinical implications of the collapsed cone planning algorithm. Clin Oncol (R Coll Radiol) 2004;16:148-54.
14. De Jaeger K, Hoogeman MS, Engelsman M, Seppenwoolde Y, Damen EM, Mijnheer BJ, et al. Incorporating an improved dose-calculation algorithm in conformal radiotherapy of lung cancer: re-evaluation of dose in normal lung tissue. Radiother Oncol 2003;69:1-10.
15. Satoshi I, Keiji N, Atushi O, Narikazu B. Long-term toxicity after definitive chemoradiotherapy for squamous cell carcinoma of the thoracic esophagus. J Clin Oncol 2003;21:2697-702.
16. Mukherjee S, Aston D, Minettt M, Brewster AE, Crosby TDL. The significance of cardiac doses received during chemoradiation of oesophageal and gastro-oesophageal junctional cancers. Clin Oncol (R Coll Radiol) 2003;15:115-20.
17. Stewart JR, Fajardo LF, Gillette SM, Constine LS. Radiation injury to the heart. Int J Radiat Oncol Biol Phys 1995;31:1205-11.
18. Seddon B, Cook A, Gothard L, Salmon E, Latus K, Underwood SR, et al. Detection of defects in myocardial perfusion imaging in patients with early breast cancer treated with radiotherapy. Radiother Oncol 2002;64:53-63.